{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T16:03:13Z","timestamp":1788624193487,"version":"build-2803163510"},"reference-count":53,"publisher":"MDPI AG","issue":"23","license":[{"start":{"date-parts":[[2021,11,26]],"date-time":"2021-11-26T00:00:00Z","timestamp":1637884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["19H03842, 19K10246, 19K24146"],"award-info":[{"award-number":["19H03842, 19K10246, 19K24146"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Medication-related osteonecrosis of the jaw (MRONJ) is related to impaired bone healing conditions in the maxillomandibular bone region as a complication of bisphosphonate intake. Although there are several hypotheses for the onset of MRONJ symptoms, one of the possible causes is the inhibition of bone turnover and blood supply leading to bone necrosis. The optimal treatment strategy for MRONJ has not been established either. BMP-2, a member of the TGF-\u03b2 superfamily, is well known for regulating bone remodeling and homeostasis prenatally and postnatally. Therefore, the objectives of this study were to evaluate whether cyclophosphamide\/zoledronate (CY\/ZA) induces necrosis of the bone surrounding the tooth extraction socket, and to examine the therapeutic potential of BMP-2 in combination with the hard osteoinductive biomaterial, \u03b2-tricalcium phosphate (\u03b2-TCP), in the prevention and treatment of alveolar bone loss around the tooth extraction socket in MRONJ-like mice models. First, CY\/ZA was intraperitoneally administered for three weeks, and alveolar bone necrosis was evaluated before and after tooth extraction. Next, the effect of BMP-2\/\u03b2-TCP was investigated in both MRONJ-like prevention and treatment models. In the prevention model, CY\/ZA was continuously administered for four weeks after BMP-2\/\u03b2-TCP transplantation. In the treatment model, CY\/ZA administration was suspended after transplantation of BMP-2\/\u03b2-TCP. The results showed that CY\/ZA induced a significant decrease in the number of empty lacunae, a sign of bone necrosis, in the alveolar bone around the tooth extraction socket after tooth extraction. Histological analysis showed a significant decrease in the necrotic alveolar bone around tooth extraction sockets in the BMP-2\/\u03b2-TCP transplantation group compared to the non-transplanted control group in both MRONJ-like prevention and treatment models. However, bone mineral density, determined by micro-CT analysis, was significantly higher in the BMP-2\/\u03b2-TCP transplanted group than in the control group in the prevention model only. These results clarified that alveolar bone necrosis around tooth extraction sockets can be induced after surgical intervention under CY\/ZA administration. In addition, transplantation of BMP-2\/\u03b2-TCP reduced the necrotic alveolar bone around the tooth extraction socket. Therefore, a combination of BMP-2\/\u03b2-TCP could be an alternative approach for both prevention and treatment of MRONJ-like symptoms.<\/jats:p>","DOI":"10.3390\/ijms222312823","type":"journal-article","created":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T23:22:28Z","timestamp":1638314548000},"page":"12823","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Suppression of Bone Necrosis around Tooth Extraction Socket in a MRONJ-like Mouse Model by E-rhBMP-2 Containing Artificial Bone Graft Administration"],"prefix":"10.3390","volume":"22","author":[{"given":"Yukie","family":"Tanaka","sequence":"first","affiliation":[{"name":"Department of Molecular Biology and Biochemistry, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan"},{"name":"Department of Oral Rehabilitation and Regenerative Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyaw Thu","family":"Aung","sequence":"additional","affiliation":[{"name":"Department of Oral Rehabilitation and Regenerative Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuaki","family":"Ono","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology and Biochemistry, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan"},{"name":"Department of Oral Rehabilitation and Implantology, Okayama University Hospital, Okayama 700-8558, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Mikai","sequence":"additional","affiliation":[{"name":"Department of Oral Rehabilitation and Implantology, Okayama University Hospital, Okayama 700-8558, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anh Tuan","family":"Dang","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology and Biochemistry, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan"},{"name":"Department of Oral Rehabilitation and Regenerative Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7374-3487","authenticated-orcid":false,"given":"Emilio Satoshi","family":"Hara","sequence":"additional","affiliation":[{"name":"Department of Biomaterials, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikue","family":"Tosa","sequence":"additional","affiliation":[{"name":"Department of Oral Rehabilitation and Regenerative Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Ishibashi","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology and Biochemistry, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan"},{"name":"Department of Oral Rehabilitation and Regenerative Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya","family":"Ono-Kimura","sequence":"additional","affiliation":[{"name":"Department of Oral Rehabilitation and Implantology, Okayama University Hospital, Okayama 700-8558, Japan"},{"name":"Center for Innovative Clinical Medicine, Okayama University Hospital, Okayama 700-8558, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumiko","family":"Nawachi","sequence":"additional","affiliation":[{"name":"Department of Oral Rehabilitation and Implantology, Okayama University Hospital, Okayama 700-8558, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3756-2835","authenticated-orcid":false,"given":"Takuo","family":"Kuboki","sequence":"additional","affiliation":[{"name":"Department of Oral Rehabilitation and Regenerative Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan"},{"name":"Department of Oral Rehabilitation and Implantology, Okayama University Hospital, Okayama 700-8558, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9302-1913","authenticated-orcid":false,"given":"Toshitaka","family":"Oohashi","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology and Biochemistry, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,11,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: A growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.1200\/JCO.2003.08.017","article-title":"American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer","volume":"21","author":"Hillner","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e2014","DOI":"10.1097\/MD.0000000000002014","article-title":"Bisphosphonates in the Treatment of Patients with Metastatic Breast, Lung, and Prostate Cancer: A Meta-Analysis","volume":"94","author":"Liu","year":"2015","journal-title":"Medicine"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.bone.2011.04.022","article-title":"Bisphosphonates: The first 40 years","volume":"49","author":"Russell","year":"2011","journal-title":"Bone"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1056\/NEJM199612123352401","article-title":"Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. Protocol 19 Aredia Breast Cancer Study Group","volume":"335","author":"Hortobagyi","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cden.2007.09.002","article-title":"Biophosphonate-related osteonecrosis of the jaws","volume":"52","author":"Ruggiero","year":"2008","journal-title":"Dent. Clin. N. Am."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1056\/NEJM199602223340802","article-title":"Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma. Myeloma Aredia Study Group","volume":"334","author":"Berenson","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1007\/s00520-020-05600-z","article-title":"Pain characteristics in medication-related osteonecrosis of the jaws","volume":"29","author":"Haviv","year":"2021","journal-title":"Support Care Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.coms.2015.06.008","article-title":"Diagnosis and Staging of Medication-Related Osteonecrosis of the Jaw","volume":"27","author":"Ruggiero","year":"2015","journal-title":"Oral Maxillofac. Surg. Clin. N. Am."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jbmr.2405","article-title":"Diagnosis and management of osteonecrosis of the jaw: A systematic review and international consensus","volume":"30","author":"Khan","year":"2015","journal-title":"J. Bone Miner. Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s00198-015-3335-3","article-title":"Osteonecrosis of the jaw (ONJ): Diagnosis and management in 2015","volume":"27","author":"Khan","year":"2016","journal-title":"Osteoporos. Int."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.job.2019.03.005","article-title":"Medication-related osteonecrosis of the jaw: A literature review","volume":"61","author":"Kuroshima","year":"2019","journal-title":"J. Oral Biosci."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jormas.2017.06.012","article-title":"Update MRONJ and perspectives of its treatment","volume":"118","author":"Voss","year":"2017","journal-title":"J. Stomatol. Oral Maxillofac. Surg."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1634\/theoncologist.2010-0183","article-title":"Quality of life implications of bisphosphonate-associated osteonecrosis of the jaw","volume":"16","author":"Miksad","year":"2011","journal-title":"Oncologist"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.oooo.2018.09.008","article-title":"Medication-related osteonecrosis of the jaw: Definition and best practice for prevention, diagnosis, and treatment","volume":"127","author":"Schiodt","year":"2019","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"iii124","DOI":"10.1093\/annonc\/mdu103","article-title":"Bone health in cancer patients: ESMO Clinical Practice Guidelines","volume":"25","author":"Coleman","year":"2014","journal-title":"Ann. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw\u20142014 update","volume":"72","author":"Ruggiero","year":"2014","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00774-010-0162-7","article-title":"Bisphosphonate-related osteonecrosis of the jaw: Position paper from the Allied Task Force Committee of Japanese Society for Bone and Mineral Research, Japan Osteoporosis Society, Japanese Society of Periodontology, Japanese Society for Oral and Maxillofacial Radiology, and Japanese Society of Oral and Maxillofacial Surgeons","volume":"28","author":"Yoneda","year":"2010","journal-title":"J. Bone Miner. Metab."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41368-020-00093-2","article-title":"Pathogenesis and multidisciplinary management of medication-related osteonecrosis of the jaw","volume":"12","author":"He","year":"2020","journal-title":"Int. J. Oral Sci."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Lorenzo-Pouso, A.I., Bagan, J., Bagan, L., Gandara-Vila, P., Chamorro-Petronacci, C.M., Castelo-Baz, P., Blanco-Carrion, A., Blanco-Fernandez, M.A., Alvarez-Calderon, O., and Carballo, J. (2021). Medication-Related Osteonecrosis of the Jaw: A Critical Narrative Review. J. Clin. Med., 10.","DOI":"10.3390\/jcm10194367"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Bacci, C., Cerrato, A., Bardhi, E., Frigo, A.C., Djaballah, S.A., and Sivolella, S. (2021). A retrospective study on the incidence of medication-related osteonecrosis of the jaws (MRONJ) associated with different preventive dental care modalities. Support Care Cancer.","DOI":"10.1007\/s00520-021-06587-x"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1002\/jbmr.3237","article-title":"Short-Term Teriparatide and Recombinant Human Bone Morphogenetic Protein-2 for Regenerative Approach to Medication-Related Osteonecrosis of the Jaw: A Preliminary Study","volume":"32","author":"Jung","year":"2017","journal-title":"J. Bone Miner. Res."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"On, S.W., Cho, S.W., Byun, S.H., and Yang, B.E. (2021). Various Therapeutic Methods for the Treatment of Medication-Related Osteonecrosis of the Jaw (MRONJ) and Their Limitations: A Narrative Review on New Molecular and Cellular Therapeutic Approaches. Antioxidants, 10.","DOI":"10.3390\/antiox10050680"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/wdev.86","article-title":"The TGFbeta superfamily signaling pathway","volume":"2","author":"Weiss","year":"2013","journal-title":"Wiley Interdiscip. Rev. Dev. Biol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"15005","DOI":"10.1038\/boneres.2015.5","article-title":"TGF-beta\/BMP signaling and other molecular events: Regulation of osteoblastogenesis and bone formation","volume":"3","author":"Rahman","year":"2015","journal-title":"Bone Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00024720-200210000-00001","article-title":"Anterior lumbar interbody fusion using rhBMP-2 with tapered interbody cages","volume":"15","author":"Burkus","year":"2002","journal-title":"J. Spinal Disord Tech."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"S146","DOI":"10.2106\/00004623-200100002-00009","article-title":"Application of bone morphogenetic proteins in the treatment of clinical oral and maxillofacial osseous defects","volume":"83","author":"Boyne","year":"2001","journal-title":"J. Bone Joint Surg. Am."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1902\/jop.1999.70.2.139","article-title":"Recombinant human bone morphogenetic protein-2 stimulation of bone formation around endosseous dental implants","volume":"70","author":"Cochran","year":"1999","journal-title":"J. Periodontol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"S136","DOI":"10.2106\/00004623-200100002-00008","article-title":"Augmentation of alveolar bone and dental implant osseointegration: Clinical implications of studies with rhBMP-2","volume":"83","author":"Wikesjo","year":"2001","journal-title":"J. Bone Jt. Surg. Am."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00774-009-0040-3","article-title":"Osteoinductive capacity and heat stability of recombinant human bone morphogenetic protein-2 produced by Escherichia coli and dimerized by biochemical processing","volume":"27","author":"Yano","year":"2009","journal-title":"J. Bone Miner. Metab."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/j.joms.2009.08.028","article-title":"Early implant survival in posterior maxilla with or without beta-tricalcium phosphate sinus floor graft","volume":"68","author":"Uckan","year":"2010","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/term.1705","article-title":"In vitro and in vivo enhancement of osteogenic capacity in a synthetic BMP-2 derived peptide-coated mineralized collagen composite","volume":"10","author":"Zhang","year":"2016","journal-title":"J. Tissue Eng. Regen. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000369061","article-title":"Efficient bone formation in a swine socket lift model using Escherichia coli-derived recombinant human bone morphogenetic protein-2 adsorbed in beta-tricalcium phosphate","volume":"199","author":"Ono","year":"2014","journal-title":"Cells Tissues Organs"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Mikai, A., Ono, M., Tosa, I., Nguyen, H.T.T., Hara, E.S., Nosho, S., Kimura-Ono, A., Nawachi, K., Takarada, T., and Kuboki, T. (2020). BMP-2\/\u03b2-TCP Local Delivery for Bone Regeneration in MRONJ-Like Mouse Model. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21197028"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S8756-3282(00)00358-6","article-title":"Direct stimulation of osteoclastic bone resorption by bone morphogenetic protein (BMP)-2 and expression of BMP receptors in mature osteoclasts","volume":"27","author":"Kaneko","year":"2000","journal-title":"Bone"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"3656","DOI":"10.1210\/endo.142.8.8300","article-title":"Bone morphogenetic protein 2 stimulates osteoclast differentiation and survival supported by receptor activator of nuclear factor-kappaB ligand","volume":"142","author":"Itoh","year":"2001","journal-title":"Endocrinology"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1089\/ten.tea.2018.0326","article-title":"Effects of Bone Morphogenetic Protein-2 on Neovascularization During Large Bone Defect Regeneration","volume":"25","author":"Pearson","year":"2019","journal-title":"Tissue Eng. Part A"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.coms.2007.01.005","article-title":"Osteonecrosis and bisphosphonates in oral and maxillofacial surgery","volume":"19","author":"Chaudhry","year":"2007","journal-title":"Oral Maxillofac. Surg. Clin. N. Am."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.spinee.2013.08.060","article-title":"Complications with the use of bone morphogenetic protein 2 (BMP-2) in spine surgery","volume":"14","author":"Tannoury","year":"2014","journal-title":"Spine J."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"4363","DOI":"10.12659\/MSM.905958","article-title":"Association of Bone Morphogenetic Protein (BMP)\/Smad Signaling Pathway with Fracture Healing and Osteogenic Ability in Senile Osteoporotic Fracture in Humans and Rats","volume":"24","author":"Liu","year":"2018","journal-title":"Med. Sci. Monit."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1002\/jbmr.3191","article-title":"Evaluation of the Treatment Strategies for Medication-Related Osteonecrosis of the Jaws (MRONJ) and the Factors Affecting Treatment Outcome: A Multicenter Retrospective Study with Propensity Score Matching Analysis","volume":"32","author":"Hayashida","year":"2017","journal-title":"J. Bone Miner. Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jcms.2020.01.014","article-title":"Is the application of platelet concentrates effective in the prevention and treatment of medication-related osteonecrosis of the jaw? A systematic review","volume":"48","author":"Fortunato","year":"2020","journal-title":"J. Craniomaxillofac. Surg."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Mauceri, R., Panzarella, V., Pizzo, G., Oteri, G., Cervino, G., Mazzola, G., Di Fede, O., and Campisi, G. (2020). Platelet-Rich Plasma (PRP) in Dental Extraction of Patients at Risk of Bisphosphonate-Related Osteonecrosis of the Jaws: A Two-Year Longitudinal Study. Appl. Dentistry Oral Sci., 10.","DOI":"10.3390\/app10134487"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s12663-013-0605-5","article-title":"Clinical evaluation of use of platelet rich plasma in bone healing","volume":"14","author":"Gawai","year":"2015","journal-title":"J. Maxillofac. Oral Surg."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.coms.2015.06.001","article-title":"Pathophysiology of Osteonecrosis of the Jaws","volume":"27","author":"Aghaloo","year":"2015","journal-title":"Oral Maxillofac. Surg. Clin. N. Am."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1097\/00007632-200208151-00002","article-title":"Overview of bone morphogenetic proteins","volume":"27","author":"Wozney","year":"2002","journal-title":"Spine"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1749-799X-6-8","article-title":"The role of FGF-2 and BMP-2 in regulation of gene induction, cell proliferation and mineralization","volume":"6","author":"Li","year":"2011","journal-title":"J. Orthop. Surg. Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e1900226","DOI":"10.1002\/mabi.201900226","article-title":"Investigation of Sustained BMP Delivery in the Prevention of Medication-Related Osteonecrosis of the Jaw (MRONJ) in a Rat Model","volume":"19","author":"Brierly","year":"2019","journal-title":"Macromol. Biosci."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/00024720-200304000-00001","article-title":"Is INFUSE bone graft superior to autograft bone? An integrated analysis of clinical trials using the LT-CAGE lumbar tapered fusion device","volume":"16","author":"Burkus","year":"2003","journal-title":"J. Spinal Disord. Tech."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1902\/cap.2011.110037","article-title":"Clinical Applications of Recombinant Human Bone Morphogenetic Protein-2 for Bone Augmentation Before Dental Implant Placement","volume":"1","author":"Misch","year":"2011","journal-title":"Clin. Adv. Periodontics"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Halloran, D., Durbano, H.W., and Nohe, A. (2020). Bone Morphogenetic Protein-2 in Development and Bone Homeostasis. J. Dev. Biol., 8.","DOI":"10.3390\/jdb8030019"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1034\/j.1600-0501.2003.00921.x","article-title":"Effect of rhBMP-2 on guided bone regeneration in humans","volume":"14","author":"Jung","year":"2003","journal-title":"Clin. Oral Implant. Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.bone.2018.05.001","article-title":"Prevalence of bisphosphonate-related osteonecrosis of the jaw-like lesions is increased in a chemotherapeutic dose-dependent manner in mice","volume":"112","author":"Kuroshima","year":"2018","journal-title":"Bone"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/23\/12823\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:36:32Z","timestamp":1760168192000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/23\/12823"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,26]]},"references-count":53,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["ijms222312823"],"URL":"https:\/\/doi.org\/10.3390\/ijms222312823","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,26]]}}}